Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

56.91
Delayed Data
As of 4:00pm ET
 -0.16 / -0.28%
Today’s Change
53.63
Today|||52-Week Range
66.80
-3.33%
Year-to-Date
MRK Regular Dividend: MRK will begin trading ex-dividend on 12/14/17 with a $0.48 dividend payable to shareholders of record as of 12/15/17.
Novice Trade: Pfizer
9:03am / TheStreet.com - Paid Partner Content
52-Week Company Lows
Dec 07 / GuruFocus News - Paid Partner Content
Merck's Keytruda Gets FDA Priority Review for Rare Lymphoma
Dec 12 / Zacks.com - Paid Partner Content
US Market Indexes Lower, Tech Stocks Report a Gain
Dec 07 / GuruFocus News - Paid Partner Content
US Market Indexes Higher on Monday
Dec 12 / GuruFocus News - Paid Partner Content
Novo Nordisk's Semaglutide Gets FDA Approval for Diabetes
Dec 06 / Zacks.com - Paid Partner Content
4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018
Dec 11 / Zacks.com - Paid Partner Content
Can Drug/Biotech M&A Rebound Next Year After Bleak 2017?
Dec 06 / Zacks.com - Paid Partner Content
US Market Indexes Higher on Friday
Dec 08 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Home Depot, Boeing, Merck, Allstate and Illumina
Dec 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close57.07
Today’s open56.94
Day’s range56.65 - 57.37
Volume13,342,531
Average volume (3 months)10,107,646
Market cap$155.7B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+4.29%
Earnings growth (next 5 years)+4.15%
Revenue growth (last year)+1.86%
P/E ratio54.9
Price/Sales4.15
Price/Book3.91

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.20+0.24%
PFEPfizer+0.06+0.16%
SNYSanofi-0.04-0.09%
ABBVAbbVie+1.05+1.09%
Data as of 4:02pm ET, 12/13/2017

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$0.94
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts